Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...

JP Morgan upgrades Amneal Pharmaceuticals, citing strong Crexont sales, robust generics growth, and a higher 2025 revenue ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

ANI Pharmaceuticals beat Q4 estimates with strong sales growth and raised its 2025 revenue and EPS outlook, driven by ...

The differences between the generics industry and other pharma companies wouldn’t exist without patents – legal titles that exclude others from producing or using an invention or innovation ...

A Tebra survey found that 84% of Americans believe generic medications are just as effective as their brand-name counterparts ...

I asked Sandy, Mira and David for tips to save on prescription drugs. Sandy also highlighted using of generics for easy ...

Reports Q4 revenue $190.6M vs. $131.65M last year. Nikhil Lalwani, President and CEO of ANI stated, “We’re thrilled to report another year of ...

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics ...

Imagine walking to your local pharmacy — the one your family has trusted for years — only to find it shuttered. This is ...

The Ireland-headquartered Felix Pharmaceuticals, which is eyeing a valuation of around $200-250 million for the controlling ...